Inventor
CHEN ZHUOLIANG
US33 patents
⚠️ This page may combine multiple inventors who share the name “CHEN ZHUOLIANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVARTIS AG
17 patentsUS7419975B2Sep 2, 2008
Organic compounds
NOVARTIS AG80 citations94
US10968235B2Apr 6, 2021
N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2
NOVARTIS AG3 citations83
US10336774B2Jul 2, 2019
N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2
NOVARTIS AG7 citations83
US10301278B2May 28, 2019
1-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions therefor for inhibiting the activity of SHP2
NOVARTIS AG8 citations83
US8044209B2Oct 25, 2011
Pyrrolydine derivatives as IAP inhibitors
NOVARTIS AG8 citations83
US10287266B2May 14, 2019
Compounds and compositions for inhibiting the activity of SHP2
NOVARTIS AG8 citations82
US7989441B2Aug 2, 2011
Organic compounds
NOVARTIS AG8 citations79
US10934285B2Mar 2, 2021
Compounds and compositions for inhibiting the activity of SHP2
NOVARTIS AG5 citations72
US9688672B2Jun 27, 2017
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH
NOVARTIS AG2 citations71
US9409871B2Aug 9, 2016
Pyridazinyl derivatives as SMO inhibitors
NOVARTIS AG5 citations71
US10975080B2Apr 13, 2021
Compounds and compositions for inhibiting the activity of SHP2
NOVARTIS AG2 citations70
US12209098B2Jan 28, 2025
N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2
NOVARTIS AG0 citations62
US11952386B2Apr 9, 2024
N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2
NOVARTIS AG0 citations62
US11905283B2Feb 20, 2024
Compounds and compositions for inhibiting the activity of SHP2
NOVARTIS AG0 citations62
US11401259B2Aug 2, 2022
1-Pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of SHP2
NOVARTIS AG0 citations60
US10112931B2Oct 30, 2018
3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH
NOVARTIS AG0 citations51
US8048886B2Nov 1, 2011
Substituted pyrazine-3-one-derivatives as IAP inhibitors
NOVARTIS AG0 citations40
CHEN ZHUOLIANG
5 patentsUS8546336B2Oct 1, 2013
SMAC peptidometics useful as IAP inhibitors
CHEN ZHUOLIANG15 citations90
US9815813B2Nov 14, 2017
1-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions therefor for inhibiting the activity of SHP2
CHEN ZHUOLIANG13 citations82
US10308660B2Jun 4, 2019
Compounds and compositions for inhibiting the activity of SHP2
CHEN ZHUOLIANG1 citations58
US8993523B2Mar 31, 2015
Dimeric IAP inhibitors
CHEN ZHUOLIANG2 citations50
US8058272B2Nov 15, 2011
Organic compounds
CHEN ZHUOLIANG0 citations39
CHEN CHRISTINE HIU TUNG
3 patentsUS10077276B2Sep 18, 2018
N-azaspirocycloalkane substituted N-heteroaryl compounds and compositions for inhibiting the activity of SHP2
CHEN CHRISTINE HIU TUNG15 citations91
US10093646B2Oct 9, 2018
1-pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of SHP2
CHEN CHRISTINE HIU TUNG7 citations81
US10774065B2Sep 15, 2020
1-pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of SHP2
CHEN CHRISTINE HIU TUNG0 citations49